Quantcast

Latest Mitral valve Stories

2011-08-17 06:28:00

TSX Venture Exchange: NVC --Will Fund New Initiative to Treat Mitral Valve Disease and Completion of COSIRA Trial Designed to Support Marketing Approval of Neovasc Reducer(TM) for Treatment of Refractory Angina-- VANCOUVER, Aug. 17, 2011 /PRNewswire/ - Neovasc Inc. (TSXV: NVC) today announced that it has completed a previously announced non-brokered private placement of 4,720,500 equity units at the price of $1.00 per unit for aggregate gross proceeds of approximately $4,720,500....

75da28fbfb354e1abff3b9a5a0a2a68c
2011-08-09 09:28:50

A new study into the causes of leakage in one of the heart's most complex valve structures could lead to improved diagnosis and treatment of the condition. An estimated 1.6 million Americans suffer moderate to severe leakage through their tricuspid valve, a complex structure that closes off the heart's right ventricle from the right atrium. Most people have at least some leakage in the valve, but what causes the problem is not well understood. A new study, published online in the journal...

2011-07-21 06:32:00

--Proceeds Will be Used To Fund New Initiative to Treat Mitral Valve Disease and to Complete Neovasc Reducer(TM) COSIRA Trial for Treating Refractory Angina-- TSX Venture Exchange: NVC VANCOUVER, July 21, 2011 /PRNewswire/ - Neovasc Inc. (TSXV: NVC) today announced that it intends to complete a non-brokered private placement with accredited investors of up to four million equity units at the price of $1.00 per unit for aggregate gross proceeds of up to $4.0 million. The company...

2011-06-24 23:06:56

 An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered at Rush University Medical Center to patients with severe aortic stenosis who are at high-risk or not suitable candidates for open heart valve replacement surgery. "This breakthrough technology could save the lives of thousands of patients with heart valve disease who have no other therapeutic options," says Dr. Ziyad Hijazi, director of the Rush Center for Congenital and...

2011-05-25 09:19:00

ST. LOUIS, May 25, 2011 /PRNewswire/ -- Missouri Baptist Medical Center cardiac surgeons and cardiologists are teaming up to provide better treatment options for patients with heart valve conditions. The new Heart Valve Clinic at Missouri Baptist opens June 3, offering patients with heart valve disease access to several specialists at one time in order to expedite their care and help determine the optimal treatment protocol in a setting that is convenient for the patient. "Valve...

2011-05-04 05:00:00

KIRKLAND, Wash., May 4, 2011 /PRNewswire/ -- Cardiac Dimensions®, Inc. announced today the initiation of two new clinical studies using the CARILLON® Mitral Contour System(TM), an investigational device for percutaneous treatment of Functional Mitral Regurgitation (FMR). The CARILLON system is a minimally invasive device designed to repair the heart's mitral valve and reduce FMR, a disorder that affects most of the estimated 5 million people in the U.S....

2011-04-04 08:00:00

NorthShore University HealthSystem's Ted Feldman, MD, Presents Late Breaking Data at American College of Cardiology Conference EMBARGOED FOR RELEASE UNTIL 8 AM, CDT, APRIL 4, 2011 EVANSTON, Ill., April 4, 2011 /PRNewswire-USNewswire/ -- NorthShore University HealthSystem (NorthShore) interventional cardiologist, Ted Feldman, MD, presented positive results from the EVEREST II trial (Endovascular Valve Edge-to-Edge REpair STudy), that were concurrently published in The New England Journal...

2011-03-30 08:00:00

ABBOTT PARK, Ill., March 30, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the launch of the company's catheter-based MitraClip® system for the treatment of mitral regurgitation (MR) in Australia. The MitraClip device, which has received Therapeutic Goods Administration (TGA) approval, offers a new treatment option for patients suffering from MR, a debilitating heart valve condition. Chronic, severe MR is often associated with heart failure and can result in...

2010-12-14 14:30:07

Valvular heart disease: The next cardiac epidemic The UK is poorly prepared for the forthcoming epidemic of degenerative valvular heart disease, prompted by a rapidly ageing population, say leading experts in the journal Heart. The prevalence of valvular heart disease, or VHD for short, rises with age. European and US data indicate that more than 13% of those aged 75 and above have the progressive condition. And by 2018, there will be an estimated 4 million people in the UK aged between 75...

2010-09-21 11:53:22

A percutaneous mitral valve clip designed to stop mitral valve regurgitation demonstrated clinical benefit as measured by the degree of mitral regurgitation, according to a study presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. Mitral valve regurgitation is one of the most common forms of heart disease. The study was led by James Hermiller, MD, Director of Cardiovascular Intervention at the...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related